Immunocore signs Eli Lilly in fourth T-cell collaboration
By Nuala Moran
Wednesday, July 16, 2014
LONDON The deals go on for Immunocore Ltd., which has signed Eli Lilly and Co. as the fourth partner in little over a year for its Immtac T-cell receptor technology.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.